Showing all 3 results
Bupropion tablets
FreeProduct Composition & Strength
We supply this product in three distinct Release Profiles, packed in moisture-resistant Alu-Alu or HDPE containers to protect the stability of the hydrochloride salt.
Release Profile Strength Primary Clinical Function Bupropion XL (Extended Release) 150 mg / 300 mg The Depression Anchor: Once-daily dosing (24-hour release) for MDD and Seasonal Affective Disorder. Bupropion SR (Sustained Release) 150 mg The Smoking Cessation Specialist: Twice-daily dosing (12-hour release) for smoking cessation and MDD. Bupropion IR (Immediate Release) 75 mg / 100 mg The Titration Unit: Immediate-release format for precise dose escalation under specialist supervision. Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Clozapine Tablets
FreeProduct Composition & Available Titration Strengths
Because Clozapine demands highly delicate, low-dose initial titration to protect the patient’s cardiovascular profile, we manufacture the full compendial strength spectrum.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clozapine USP / BP / IP 25 mg Oral Solid Uncoated Micro-Tablet Introductory Safety Titration: Mandatory low-dose baseline format utilized exclusively for the initial day 1 and day 2 dose-escalation phase to prevent orthostatic shock. Clozapine USP / BP / IP 50 mg Oral Solid Uncoated Micro-Tablet Intermediate Dose Step-Up: Mid-tier titration strength engineered to scale up systemic tolerance during weeks 1 and 2. Clozapine USP / BP / IP 100 mg Oral Solid Compressed Tablet The Core Commercial Volume: First-line international standard target maintenance strength for adult refractory schizophrenia management.
